We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-1.04%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.6B
AUM Growth
-$2.31B
(-5.8%)
Cap. Flow
-$309M
Cap. Flow
% of AUM
-0.82%
Top 10 Holdings %
Top 10 Hldgs %
14.09%
Holding
3,035
New
443
Increased
1,011
Reduced
1,232
Closed
320
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$465M |
| 2 |
Amazon
AMZN
|
+$304M |
| 3 |
Apple
AAPL
|
+$297M |
| 4 |
Occidental Petroleum
OXY
|
+$286M |
| 5 |
Zoom
ZM
|
+$259M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$395M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$373M |
| 3 |
Caterpillar
CAT
|
+$297M |
| 4 |
Intel
INTC
|
+$277M |
| 5 |
NVIDIA
NVDA
|
+$236M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.58% |
| 2 | Healthcare | 20.45% |
| 3 | Consumer Discretionary | 10.84% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Immuneering
IMRX
$267M
| $86K | ﹤0.01% |
+13,300
| New | +$128K |
|
|
NMTR
2527
DELISTED
9 Meters Biopharma
NMTR
| $86K | ﹤0.01% |
7,205
-335
| -4% | -$4.57K |
|
|
ZY
2528
DELISTED
Zymergen Inc. Common Stock
ZY
| $86K | ﹤0.01% |
+29,700
| New | +$126K |
|
2529
Energous
WATT
$77.6M
| $85K | ﹤0.01% |
118
+41
| +53% | +$28.4K |
|
2530
Spire Global
SPIR
$443M
| $83K | ﹤0.01% |
4,938
-675
| -12% | -$13.2K |
|
|
VIRX
2531
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $83K | ﹤0.01% |
17,418
-30,726
| -64% | -$92.6K |
|
2532
IRIDEX
IRIX
$14.3M
| $81K | ﹤0.01% |
17,600
-1,100
| -6% | -$5.43K |
|
2533
Lloyds Banking Group
LYG
$89.5B
| $80K | ﹤0.01% |
+33,032
| New | +$87.8K |
|
|
LYRA
2534
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $80K | ﹤0.01% |
400
-734
| -65% | -$161K |
|
2535
Innodata
INOD
$2.05B
| $79K | ﹤0.01% |
11,300
-8,800
| -44% | -$51.7K |
|
2536
Plus Therapeutics
PSTV
$26.8M
| $79K | ﹤0.01% |
211
-493
| -70% | -$188K |
|
|
WHLM
2537
DELISTED
Wilhelmina International, Inc
WHLM
| $78K | ﹤0.01% |
16,700
-12,200
| -42% | -$54.2K |
|
2538
Cognition Therapeutics
CGTX
$79.7M
| $77K | ﹤0.01% |
28,100
-40,800
| -59% | -$157K |
|
|
XNET
2539
Xunlei
XNET
$339M
| $77K | ﹤0.01% |
43,900
-42,700
| -49% | -$73.6K |
|
|
BIOC
2540
DELISTED
Biocept, Inc.
BIOC
| $77K | ﹤0.01% |
1,100
-183
| -14% | -$14.4K |
|
|
RNLX
2541
DELISTED
Renalytix plc American Depositary Shares
RNLX
| $76K | ﹤0.01% |
11,000
-1,200
| -10% | -$12.7K |
|
2542
Five Point Holdings
FPH
$377M
| $75K | ﹤0.01% |
12,300
-18,600
| -60% | -$114K |
|
|
AWH
2543
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $73K | ﹤0.01% |
4,693
-8,107
| -63% | -$140K |
|
|
FRSX
2544
Foresight Autonomous Holdings
FRSX
$3.73M
| $72K | ﹤0.01% |
518
-33
| -6% | -$5.45K |
|
|
CAN
2545
Canaan Creative
CAN
$142M
| $71K | ﹤0.01% |
13,100
-9,500
| -42% | -$47.5K |
|
|
OTRK
2546
DELISTED
Ontrak
OTRK
| $71K | ﹤0.01% |
+347
| New | +$94.5K |
|
|
GTH
2547
DELISTED
Genetron Holdings Limited ADS
GTH
| $71K | ﹤0.01% |
10,867
-14,066
| -56% | -$154K |
|
2548
Abits Group
ABTS
$3.17M
| $70K | ﹤0.01% |
2,920
-60
| -2% | -$1.77K |
|
|
ASTR
2549
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $70K | ﹤0.01% |
+1,207
| New | +$79.7K |
|
2550
Joby Aviation
JOBY
$7.03B
| $69K | ﹤0.01% |
10,400
-80,300
| -89% | -$414K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q1 2022 Portfolio in Review
As of Q1 2022, Two Sigma Advisers held 3,035 positions worth $37.6B, down 5.8% from $39.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers's Q1 2022 filing shows 443 new, 1,011 increased, 1,232 reduced and 320 closed positions. Its largest new stake was PepsiCo: 1,100,300 shares worth $184M. The largest sale was Coca-Cola, an estimated $395M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Two Sigma Advisers's largest Q1 2022 buy was PepsiCo: 1,100,300 shares worth $184M.
- Two Sigma Advisers added most to Adobe in Q1 2022, an estimated $465M increase.
- Two Sigma Advisers's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $395M.
- Two Sigma Advisers fully exited Activision Blizzard in Q1 2022, selling an estimated $373M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $37.6B portfolio in Q1 2022.
- Two Sigma Advisers opened 443 new positions and closed 320 in Q1 2022.
- Two Sigma Advisers's portfolio value fell 5.8% quarter-over-quarter to $37.6B.
Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.